PerkinElmer, Inc. (PKI)
(Delayed Data from NYSE)
$96.59 USD
+1.71 (1.80%)
Updated May 3, 2019 04:03 PM ET
After-Market: $96.59 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.59 USD
+1.71 (1.80%)
Updated May 3, 2019 04:03 PM ET
After-Market: $96.59 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Align Technology (ALGN) Q4 Earnings Top on Invisalign Sales
by Zacks Equity Research
Align Technology (ALGN) gains on solid contributions from the Clear Aligner as well as Scanner and Service segments in Q4.
Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Sales Beat (Revised)
by Zacks Equity Research
Zimmer Biomet (ZBH) rides high on Hip and S.E.T segments in Q4.
Hill-Rom (HRC) Beats Q1 Earnings and Revenues, Margins Up
by Zacks Equity Research
Hill-Rom (HRC) rides on strength in Front Line Care and Surgical Solutions segments in Q1.
Abaxis (ABAX) Beats Earnings and Revenue Estimates in Q3
by Zacks Equity Research
Abaxis (ABAX) Q3 earnings gain on strength in Medical and Veterinary segments.
PerkinElmer (PKI) Beats on Q4 Earnings, Issues 2018 Guidance
by Zacks Equity Research
Solid performance in Discovery & Analytical Solutions segment drives PerkinElmer (PKI) in Q4. A strong guidance for FY18 instills investor's optimism.
PerkinElmer Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
PerkinElmer's (PKI) shares hit a new 52-week high on the back of broad product spectrum and acquisition-led growth.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
High R&D and interest expenses are expected to hurt Waters Corp.'s (WAT) profitability in the quarter to be reported.
Key Factors to Influence PerkinElmer's (PKI) Q4 Earnings
by Zacks Equity Research
PerkinElmer (PKI) solid product portfolio, positive market trends and acquisition are likely to drive earnings in the fourth quarter.
PerkinElmer (PKI) Closes EUROIMMUN Acquisition for $1.3B
by Zacks Equity Research
PerkinElmer (PKI) focuses on inorganic growth through acquisition.
Quest Diagnostics, LabCorp Defend Lab Fee Suit Against HHS
by Zacks Equity Research
Quest Diagnostics (DGX) and LabCorp (LH) join forces to back a case slapped on HHS for unable to follow a congressional directive to devise a market-based laboratory payment system.
PerkinElmer (PKI) Beats Q3 Earnings, Updates '17 Guidance
by Zacks Equity Research
PerkinElmer (PKI) posted stellar third-quarter numbers from strong performance in particularly the Diagnostics segment.
Key Factors to Influence PerkinElmer's (PKI) Q3 Earnings
by Zacks Equity Research
PerkinElmer's (PKI) divestiture of the Medical Imaging segment in the last quarter is expected to impact earnings this season.
PerkinElmer Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
PerkinElmer's (PKI) portfolio has not only boosted the company's organic growth trajectory but has also helped boost market share worldwide. Solid estimate revision trend boosts investor confidence.
VWR's New Kitting Center in Czech Republic to Boost EMEA Arm
by Zacks Equity Research
VWR's new strategically located 35,000 square foot facility in Skalice, Czech Republic looks to drive the company's business growth in the high-prospect EMEA region.
PerkinElmer Strong on Product Lineup Amid Integration Risks
by Zacks Equity Research
PerkinElmer's (PKI) expanding product portfolio helps it gain global market share. However, the company's regular acquisitions pose integration risks.
PerkinElmer (PKI) Meets Q2 Earnings, Raises '17 Guidance
by Zacks Equity Research
PerkinElmer (PKI) posts tepid numbers in second quarter with in-line earnings and revenues missing the mark.
Can PerkinElmer (PKI) Spring a Surprise in Q2 Earnings?
by Zacks Equity Research
Despite an upbeat outlook, volatility in the foreign exchange rate is likely to mar PerkinElmer's (PKI) results in the second quarter.
Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp. (WAT) second-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Asia.
PerkinElmer (PKI) Hits a 52-Week High on Multiple Positives
by Zacks Equity Research
PerkinElmer Inc. (PKI) rallied to a new 52-week high of $69.19 on Jul 3, closing lower at $67.73.
PerkinElmer (PKI) to Acquire German Firm EUROIMMUN for $1.3B
by Zacks Equity Research
PerkinElmer Inc. (PKI) recently announced that it will acquire EUROIMMUN Medical Laboratory Diagnostics AG for approximately $1.3 billion in cash.
PerkinElmer (PKI) Up 5.8% Since Earnings Report: Can It Continue?
by Zacks Equity Research
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PerkinElmer (PKI) Tops Q1 Earnings Estimates, FY17 View Up
by Zacks Equity Research
PerkinElmer Inc (PKI) reported first-quarter 2017 adjusted earnings of 55 cents per share, marginally beating the Zacks Consensus Estimate by a penny.
Mettler-Toledo (MTD) Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Mettler-Toledo International Inc. (MTD) will report first-quarter 2017 earnings on May 4 after the bell.
Tech Stocks to Watch for Earnings on May 4: MTD, PKI & More
by Zacks Equity Research
Investors seem to be rejoicing as most of the companies in the technology sector surpassed estimates last week, particularly revenue estimates.
Can PerkinElmer (PKI) Deliver a Beat this Earnings Season?
by Zacks Equity Research
PerkinElmer, Inc. (PKI) is expected to release its first-quarter fiscal 2017 results on May 4, after closing bell. Let's see how things are shaping up prior to this announcement.